Please cite:
Dimitra Karagkouni, Maria D. Paraskevopoulou, Serafeim Chatzopoulos, Ioannis S. Vlachos, Spyros Tastsoglou, Ilias Kanellos, Dimitris Papadimitriou, Ioannis Kavakiotis, Sofia Maniou, Giorgos Skoufos, Thanasis Vergoulis, Theodore Dalamagas, Artemis G. Hatzigeorgiou; DIANA-TarBase v8: a decade-long collection of experimentally supported miRNA–gene interactions, Nucleic Acids Research, gkx1141, https://doi.org/10.1093/nar/gkx1141
Bulk download:
We have updated the bulk download module, which simplifies the download process! Please find the new online form by following this link

hsa-miR-942-5p


Loading... Please wait, this might take a few seconds...



Filters
Clear all
Interactions: 716, Experiments: (low: , high: , unknown: ) Cell lines: , Tissues: , Publications:
Gene name miRNA name Experiments
throughput
Publications Cell lines Tissues Pred. Score
CDKN1A hsa-miR-942-5p low: 1 high: 0 1 1 1 -
Low-throughput experiments (0 positive, 1 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Wu S et al. 2010 RP Kidney HEK293 HEK293 N/A
Location Method Result Regulation Validation Type Source
chr6:36685816-36687315 Luciferase Reporter Assay NEGATIVE DIRECT TarBase 8.0
MATR3 hsa-miR-942-5p low: 0 high: 2 2 2 1 -
High-throughput experiments (2 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Grosswendt S et al. 2014 IP Kidney HEK293 N/A N/A
Location Method Result Regulation Validation Type Source
chr5:139307911-139307937 Chimeric fragments POSITIVE DIRECT TarBase 8.0
Karginov FV et al. 2013 IP Kidney 293S N/A treatment: arsenite
Location Method Result Regulation Validation Type Source
chr5:139307948-139307973 HITS-CLIP POSITIVE DIRECT TarBase 7.0
GTPBP2 hsa-miR-942-5p low: 0 high: 2 2 2 1 -
High-throughput experiments (2 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A no treatment (control)
Location Method Result Regulation Validation Type Source
chr6:43626225-43626246 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Helwak Aleksandra et al. 2013 IP Kidney FLPIN_TREX_293 N/A N/A
Location Method Result Regulation Validation Type Source
chr6:43621206-43621257 CLASH POSITIVE DIRECT TarBase 7.0
COMMD2 hsa-miR-942-5p low: 0 high: 1 1 1 1 -
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Grosswendt S et al. 2014 IP Kidney HEK293 N/A N/A
Location Method Result Regulation Validation Type Source
chr3:149738499-149738528 Chimeric fragments POSITIVE DIRECT TarBase 8.0
FASTKD5 hsa-miR-942-5p low: 0 high: 1 1 1 1 -
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Grosswendt S et al. 2014 IP Kidney HEK293 N/A N/A
Location Method Result Regulation Validation Type Source
chr20:3146631-3146660 Chimeric fragments POSITIVE DIRECT TarBase 8.0
EML2 hsa-miR-942-5p low: 0 high: 13 1 1 1 -
High-throughput experiments (13 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A treatment:hippuristanol
Location Method Result Regulation Validation Type Source
chr19:45639007-45639028 HITS-CLIP POSITIVE DIRECT TarBase 7.0
chr19:45639007-45639028 HITS-CLIP POSITIVE DIRECT TarBase 7.0
chr19:45639007-45639028 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Karginov FV et al. 2013 IP Kidney 293S N/A treatment: emetine
Location Method Result Regulation Validation Type Source
chr19:45639007-45639028 HITS-CLIP POSITIVE DIRECT TarBase 7.0
chr19:45639007-45639028 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Karginov FV et al. 2013 IP Kidney 293S N/A treatment: arsenite
Location Method Result Regulation Validation Type Source
chr19:45639007-45639028 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Karginov FV et al. 2013 IP Kidney 293S N/A no treatment (control)
Location Method Result Regulation Validation Type Source
chr19:45639007-45639028 HITS-CLIP POSITIVE DIRECT TarBase 7.0
chr19:45639007-45639028 HITS-CLIP POSITIVE DIRECT TarBase 7.0
chr19:45639007-45639028 HITS-CLIP POSITIVE DIRECT TarBase 7.0
chr19:45639007-45639028 HITS-CLIP POSITIVE DIRECT TarBase 7.0
chr19:45639007-45639028 HITS-CLIP POSITIVE DIRECT TarBase 7.0
chr19:45639007-45639028 HITS-CLIP POSITIVE DIRECT TarBase 7.0
chr19:45639007-45639028 HITS-CLIP POSITIVE DIRECT TarBase 7.0
SPIRE1 hsa-miR-942-5p low: 0 high: 11 1 1 1 -
High-throughput experiments (11 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A treatment:hippuristanol
Location Method Result Regulation Validation Type Source
chr18:12449417-12449445 HITS-CLIP POSITIVE DIRECT TarBase 7.0
chr18:12449417-12449445 HITS-CLIP POSITIVE DIRECT TarBase 7.0
chr18:12449417-12449445 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Karginov FV et al. 2013 IP Kidney 293S N/A treatment: emetine
Location Method Result Regulation Validation Type Source
chr18:12449417-12449445 HITS-CLIP POSITIVE DIRECT TarBase 7.0
chr18:12449417-12449445 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Karginov FV et al. 2013 IP Kidney 293S N/A treatment: arsenite
Location Method Result Regulation Validation Type Source
chr18:12449417-12449445 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Karginov FV et al. 2013 IP Kidney 293S N/A no treatment (control)
Location Method Result Regulation Validation Type Source
chr18:12449417-12449445 HITS-CLIP POSITIVE DIRECT TarBase 7.0
chr18:12449417-12449445 HITS-CLIP POSITIVE DIRECT TarBase 7.0
chr18:12449417-12449445 HITS-CLIP POSITIVE DIRECT TarBase 7.0
chr18:12449417-12449445 HITS-CLIP POSITIVE DIRECT TarBase 7.0
chr18:12449417-12449445 HITS-CLIP POSITIVE DIRECT TarBase 7.0
HSPA8 hsa-miR-942-5p low: 0 high: 8 1 1 1 -
High-throughput experiments (8 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A treatment:hippuristanol
Location Method Result Regulation Validation Type Source
chr11:123059898-123059920 HITS-CLIP POSITIVE DIRECT TarBase 7.0
chr11:123059898-123059920 HITS-CLIP POSITIVE DIRECT TarBase 7.0
chr11:123059898-123059920 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Karginov FV et al. 2013 IP Kidney 293S N/A treatment: emetine
Location Method Result Regulation Validation Type Source
chr11:123059898-123059920 HITS-CLIP POSITIVE DIRECT TarBase 7.0
chr11:123059898-123059920 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Karginov FV et al. 2013 IP Kidney 293S N/A treatment: arsenite
Location Method Result Regulation Validation Type Source
chr11:123059898-123059920 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Karginov FV et al. 2013 IP Kidney 293S N/A no treatment (control)
Location Method Result Regulation Validation Type Source
chr11:123059898-123059920 HITS-CLIP POSITIVE DIRECT TarBase 7.0
chr11:123059898-123059920 HITS-CLIP POSITIVE DIRECT TarBase 7.0
SV2A hsa-miR-942-5p low: 0 high: 7 1 1 1 0.682
High-throughput experiments (7 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A treatment:hippuristanol
Location Method Result Regulation Validation Type Source
chr1:149904754-149904782 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Karginov FV et al. 2013 IP Kidney 293S N/A treatment: emetine
Location Method Result Regulation Validation Type Source
chr1:149904754-149904782 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Karginov FV et al. 2013 IP Kidney 293S N/A treatment: arsenite
Location Method Result Regulation Validation Type Source
chr1:149904754-149904782 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Karginov FV et al. 2013 IP Kidney 293S N/A no treatment (control)
Location Method Result Regulation Validation Type Source
chr1:149904754-149904782 HITS-CLIP POSITIVE DIRECT TarBase 7.0
chr1:149904754-149904782 HITS-CLIP POSITIVE DIRECT TarBase 7.0
chr1:149904754-149904782 HITS-CLIP POSITIVE DIRECT TarBase 7.0
chr1:149904754-149904782 HITS-CLIP POSITIVE DIRECT TarBase 7.0
SUMO1 hsa-miR-942-5p low: 0 high: 7 1 1 1 0.574
High-throughput experiments (7 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A treatment:hippuristanol
Location Method Result Regulation Validation Type Source
chr2:202207007-202207029 HITS-CLIP POSITIVE DIRECT TarBase 7.0
chr2:202207007-202207029 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Karginov FV et al. 2013 IP Kidney 293S N/A treatment: arsenite
Location Method Result Regulation Validation Type Source
chr2:202207007-202207029 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Karginov FV et al. 2013 IP Kidney 293S N/A no treatment (control)
Location Method Result Regulation Validation Type Source
chr2:202207007-202207029 HITS-CLIP POSITIVE DIRECT TarBase 7.0
chr2:202207007-202207029 HITS-CLIP POSITIVE DIRECT TarBase 7.0
chr2:202207007-202207029 HITS-CLIP POSITIVE DIRECT TarBase 7.0
chr2:202207007-202207029 HITS-CLIP POSITIVE DIRECT TarBase 7.0
UFD1L hsa-miR-942-5p low: 0 high: 6 2 6 2 0.458
High-throughput experiments (6 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Skalsky Rebecca L. et al. 2012 IP N/A LCLBAC N/A N/A
Location Method Result Regulation Validation Type Source
chr22:19455729-19455755 PAR-CLIP POSITIVE DIRECT TarBase 7.0
Skalsky Rebecca L. et al. 2012 IP N/A LCLBACD3 N/A N/A
Location Method Result Regulation Validation Type Source
chr22:19455729-19455755 PAR-CLIP POSITIVE DIRECT TarBase 7.0
Skalsky Rebecca L. et al. 2012 IP N/A LCLBACD1 N/A N/A
Location Method Result Regulation Validation Type Source
chr22:19455729-19455755 PAR-CLIP POSITIVE DIRECT TarBase 7.0
Skalsky Rebecca L. et al. 2012 IP N/A LCL35 N/A N/A
Location Method Result Regulation Validation Type Source
chr22:19455729-19455755 PAR-CLIP POSITIVE DIRECT TarBase 7.0
Skalsky Rebecca L. et al. 2012 IP N/A EF3DAGO2 N/A N/A
Location Method Result Regulation Validation Type Source
chr22:19455729-19455755 PAR-CLIP POSITIVE DIRECT TarBase 7.0
Eva Gottwein et al. 2011 IP Pleura BC1 N/A N/A
Location Method Result Regulation Validation Type Source
chr22:19455729-19455755 PAR-CLIP POSITIVE DIRECT TarBase 7.0
CCT4 hsa-miR-942-5p low: 0 high: 6 1 1 1 0.561
High-throughput experiments (6 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A treatment: arsenite
Location Method Result Regulation Validation Type Source
chr2:61876176-61876203 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Karginov FV et al. 2013 IP Kidney 293S N/A no treatment (control)
Location Method Result Regulation Validation Type Source
chr2:61876176-61876203 HITS-CLIP POSITIVE DIRECT TarBase 7.0
chr2:61876176-61876203 HITS-CLIP POSITIVE DIRECT TarBase 7.0
chr2:61876176-61876203 HITS-CLIP POSITIVE DIRECT TarBase 7.0
chr2:61876176-61876203 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Karginov FV et al. 2013 IP Kidney 293S N/A treatment:hippuristanol
Location Method Result Regulation Validation Type Source
chr2:61868633-61868653 HITS-CLIP POSITIVE DIRECT TarBase 7.0
HNRNPU hsa-miR-942-5p low: 0 high: 6 1 1 1 0.933
High-throughput experiments (6 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A treatment:hippuristanol
Location Method Result Regulation Validation Type Source
chr1:244858022-244858045 HITS-CLIP POSITIVE DIRECT TarBase 7.0
chr1:244858022-244858045 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Karginov FV et al. 2013 IP Kidney 293S N/A treatment: arsenite
Location Method Result Regulation Validation Type Source
chr1:244858022-244858045 HITS-CLIP POSITIVE DIRECT TarBase 7.0
chr1:244855557-244855577 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Karginov FV et al. 2013 IP Kidney 293S N/A no treatment (control)
Location Method Result Regulation Validation Type Source
chr1:244858022-244858045 HITS-CLIP POSITIVE DIRECT TarBase 7.0
chr1:244853135-244853156 HITS-CLIP POSITIVE DIRECT TarBase 7.0
HIST1H1E hsa-miR-942-5p low: 0 high: 6 1 1 1 -
High-throughput experiments (6 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A treatment: arsenite
Location Method Result Regulation Validation Type Source
chr6:26156431-26156457 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Karginov FV et al. 2013 IP Kidney 293S N/A treatment: emetine
Location Method Result Regulation Validation Type Source
chr6:26156592-26156616 HITS-CLIP POSITIVE DIRECT TarBase 7.0
chr6:26156416-26156442 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Karginov FV et al. 2013 IP Kidney 293S N/A no treatment (control)
Location Method Result Regulation Validation Type Source
chr6:26156431-26156457 HITS-CLIP POSITIVE DIRECT TarBase 7.0
chr6:26156431-26156457 HITS-CLIP POSITIVE DIRECT TarBase 7.0
chr6:26156416-26156442 HITS-CLIP POSITIVE DIRECT TarBase 7.0
CDK6 hsa-miR-942-5p low: 0 high: 5 2 2 2 0.813
High-throughput experiments (5 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Xue Y et al. 2013 IP Cervix HELA N/A Hela cells were treated with control shRNA.
Location Method Result Regulation Validation Type Source
chr7:92614874-92614901 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Karginov FV et al. 2013 IP Kidney 293S N/A treatment: emetine
Location Method Result Regulation Validation Type Source
chr7:92614874-92614901 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Karginov FV et al. 2013 IP Kidney 293S N/A treatment: arsenite
Location Method Result Regulation Validation Type Source
chr7:92614881-92614903 HITS-CLIP POSITIVE DIRECT TarBase 7.0
chr7:92614874-92614901 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Karginov FV et al. 2013 IP Kidney 293S N/A no treatment (control)
Location Method Result Regulation Validation Type Source
chr7:92614874-92614901 HITS-CLIP POSITIVE DIRECT TarBase 7.0
PPP6R1 hsa-miR-942-5p low: 0 high: 5 1 1 1 0.839
High-throughput experiments (5 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A treatment: arsenite
Location Method Result Regulation Validation Type Source
chr19:55230338-55230363 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Karginov FV et al. 2013 IP Kidney 293S N/A no treatment (control)
Location Method Result Regulation Validation Type Source
chr19:55230338-55230363 HITS-CLIP POSITIVE DIRECT TarBase 7.0
chr19:55230338-55230363 HITS-CLIP POSITIVE DIRECT TarBase 7.0
chr19:55230334-55230356 HITS-CLIP POSITIVE DIRECT TarBase 7.0
chr19:55230334-55230356 HITS-CLIP POSITIVE DIRECT TarBase 7.0
SPEN hsa-miR-942-5p low: 0 high: 5 1 1 1 0.610
High-throughput experiments (5 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A no treatment (control)
Location Method Result Regulation Validation Type Source
chr1:15939794-15939818 HITS-CLIP POSITIVE DIRECT TarBase 7.0
chr1:15931842-15931863 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Karginov FV et al. 2013 IP Kidney 293S N/A treatment: arsenite
Location Method Result Regulation Validation Type Source
chr1:15929602-15929623 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Karginov FV et al. 2013 IP Kidney 293S N/A treatment:hippuristanol
Location Method Result Regulation Validation Type Source
chr1:15848110-15848131 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Karginov FV et al. 2013 IP Kidney 293S N/A treatment: emetine
Location Method Result Regulation Validation Type Source
chr1:15848110-15848131 HITS-CLIP POSITIVE DIRECT TarBase 7.0
PANK1 hsa-miR-942-5p low: 0 high: 5 1 1 1 -
High-throughput experiments (5 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A treatment:hippuristanol
Location Method Result Regulation Validation Type Source
chr10:89583699-89583718 HITS-CLIP POSITIVE DIRECT TarBase 7.0
chr10:89583699-89583718 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Karginov FV et al. 2013 IP Kidney 293S N/A treatment: arsenite
Location Method Result Regulation Validation Type Source
chr10:89583699-89583718 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Karginov FV et al. 2013 IP Kidney 293S N/A no treatment (control)
Location Method Result Regulation Validation Type Source
chr10:89583699-89583718 HITS-CLIP POSITIVE DIRECT TarBase 7.0
chr10:89583699-89583718 HITS-CLIP POSITIVE DIRECT TarBase 7.0
CHAF1A hsa-miR-942-5p low: 0 high: 5 1 1 1 -
High-throughput experiments (5 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A treatment:hippuristanol
Location Method Result Regulation Validation Type Source
chr19:4423353-4423370 HITS-CLIP POSITIVE DIRECT TarBase 7.0
chr19:4423353-4423370 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Karginov FV et al. 2013 IP Kidney 293S N/A no treatment (control)
Location Method Result Regulation Validation Type Source
chr19:4442327-4442350 HITS-CLIP POSITIVE DIRECT TarBase 7.0
chr19:4423353-4423370 HITS-CLIP POSITIVE DIRECT TarBase 7.0
Karginov FV et al. 2013 IP Kidney 293S N/A treatment: arsenite
Location Method Result Regulation Validation Type Source
chr19:4422601-4422625 HITS-CLIP POSITIVE DIRECT TarBase 7.0
NASP hsa-miR-942-5p low: 0 high: 4 2 4 2 -
High-throughput experiments (4 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Skalsky Rebecca L. et al. 2012 IP N/A LCL35 N/A N/A
Location Method Result Regulation Validation Type Source
chr1:45607428-45607452 PAR-CLIP POSITIVE DIRECT TarBase 7.0
Skalsky Rebecca L. et al. 2012 IP N/A EF3DAGO2 N/A N/A
Location Method Result Regulation Validation Type Source
chr1:45607428-45607452 PAR-CLIP POSITIVE DIRECT TarBase 7.0
Eva Gottwein et al. 2011 IP Pleura BC3 N/A N/A
Location Method Result Regulation Validation Type Source
chr1:45607428-45607452 PAR-CLIP POSITIVE DIRECT TarBase 7.0
Eva Gottwein et al. 2011 IP Pleura BC1 N/A N/A
Location Method Result Regulation Validation Type Source
chr1:45607428-45607452 PAR-CLIP POSITIVE DIRECT TarBase 7.0